Interleukin-1 polymorphism and expression in hepatitis B virus-mediated disease outcome in India

Journal of Interferon and Cytokine Research

Volumn 33, Issue 2, 2013, Pages 80-89

  Saxena, Roli ^a   Chawla, Yogesh Kumar ^a   Verma, Indu ^a   Kaur, Jyotdeep ^a  

^a POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH   (India)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 1; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 1BETA; MESSENGER RNA;

ARTICLE; CANCER RISK; CARCINOGENESIS; CONTROLLED STUDY; DNA POLYMORPHISM; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE LINKAGE DISEQUILIBRIUM; GENETIC ASSOCIATION; GENETIC RISK; GENOTYPE; HAPLOTYPE; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; INDIA; INFECTION RISK; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

CARCINOMA, HEPATOCELLULAR; DISEASE PROGRESSION; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HEPATITIS B VIRUS; HEPATITIS B, CHRONIC; HUMANS; INDIA; INTERLEUKIN-1BETA; LIVER NEOPLASMS; MINISATELLITE REPEATS; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; RISK FACTORS;

EID: 84873640892     PISSN: 10799907     EISSN: 15577465     Source Type: Journal    
DOI: 10.1089/jir.2012.0093     Document Type: Article

References (41)

1. Bamba H, Ota S, Kato A, Matsuzaki F. 1998. Nonsteroidal anti-inflammatory drugs may delay the repair of gastric mucosa by suppressing prostaglandin-mediated increase of hepato-cyte growth factor production. Biochem Biophys Res Commun 245(2):567-571. (Pubitemid 28418546)
2. Barber MD, Powell JJ, Lynch SF, Fearon KC, Ross JA. 2000. A polymorphism of the interleukin-1 beta gene influences survival in pancreatic cancer. Br J Cancer 83(11):1443-1447.
3. Belfer I, Buzas B, Hipp H, Dean M, Evans C, Lorincz I, Max MB, Goldman D. 2004. Haplotype structure of inflammatory cy-tokines genes (IL1B, IL6 and TNF/LTA) in US Caucasians and African Americans. Genes Immun 5(6):505-512. (Pubitemid 39263886)
4. Bid HK, Konwar R, Agrawal CG, Banerjee M. 2008. Association of IL-4 and IL-1RN (receptor antagonist) gene variants and the risk of type 2 diabetes mellitus: a study in the north Indian population. Indian J Med Sci 62(7):259-266.
5. Block TM, Mehta AS, Fimmel CJ, Jordan R. 2003. Molecular viral oncology of hepatocellular carcinoma. Oncogene 22(33): 5093-5107. (Pubitemid 37059591)
6. Borzani I, Tola MR, Caniatti L, Collins A, De Santis G, Luiselli D, Mamolini E, Scapoli C. 2010. The interleukin-1 cluster gene region is associated with multiple sclerosis in an Italian Caucasian population. Eur J Neurol 17(7):930-938.
7. Boyum A. 1984. Separation of lymphocytes, granulocytes, and monocytes from human blood using iodinated density gradient media. Methods Enzymol 108:88-102. (Pubitemid 15215616)
8. Chan HL, Tse AM, Chim AM, Wong VW, Choi PC, Yu J, Zhang M, Sung JJ. 2008. Association of cytokine gene polymorphisms and liver fibrosis in chronic hepatitis B. J Gastroenterol Hepatol 23(5):783-789. (Pubitemid 351519419)
9. Chang YW, Jang JY, Kim NH, Lee JW, Lee HJ, Jung WW, Dong SH, Kim HJ, Kim BH, Lee JI, Chang R. 2005. Interleukin-1B (IL-1B) polymorphisms and gastric mucosal levels of IL-1beta cytokine in Korean patients with gastric cancer. Int J Cancer 114(3):465-471. (Pubitemid 40279971)
10. Chen CC, Yang SY, Liu CJ, Lin CL, Liaw YF, Lin SM, Lee SD, Chen PJ, Chen CJ, Yu MW. 2005. Association of cytokine and DNA repair gene polymorphisms with hepatitis B related hepatocellular carcinoma. Int J Epidemiol 34(6): 1310-1318.
11. Coleman WB. 2003. Mechanisms of human hepatocarcinogen-esis. Curr Mol Med 3(6):573-588.
12. Daly AK, Steen VM, Fairbrother KS, Idle Jr. 1996. CYP2D6 multiallelism. Methods Enzymol 272:199-210. (Pubitemid 26299883)
13. Dinarello CA. 1996. Biologic basis for interleukin-1 in disease. Blood 87(6):2095-2147. (Pubitemid 26086851)
14. El-Omar EM, Carrington M, Chow WH, McColl KE, Bream JH, Young HA, Herrera J, Lissowska J, Yuan CC, Rothman N, Lanyon G, Martin M, Fraumeni JF, Jr., Rabkin CS. 2000. Interleukin-1 polymorphisms associated with increased risk of gastric cancer. Nature 404(6776):398-402. (Pubitemid 30164342)
15. El-Omar EM, Rabkin CS, Gammon MD, Vaughan TL, Risch HA, Schoenberg JB, Stanford JL, Mayne ST, Goedert J, Blot WJ, Fraumeni JF, Jr., Chow WH. 2003. Increased risk of noncardia gastric cancer associated with proinflammatory cytokine gene polymorphisms. Gastroenterology 124(5):1193-1201. (Pubitemid 36531795)
16. Farazi PA, DePinho RA. 2006. Hepatocellular carcinoma path-ogenesis: from genes to environment. Nat Rev Cancer 6(9):674-687. (Pubitemid 44286000)
17. Glas J, Torok HP, Schneider A, Brunnler G, Kopp R, Albert ED, Stolte M, Folwaczny C. 2004. Allele 2 of the interleukin-1 receptor antagonist gene is associated with early gastric cancer. J Clin Oncol 22(23):4746-4752.
18. Hirankarn N, Kimkong I, Kummee P, Tangkijvanich P, Poovorawan Y. 2006. Interleukin-1beta gene polymorphism associated with hepatocellular carcinoma in hepatitis B virus infection. World J Gastroenterol 12(5):776-779. (Pubitemid 43380763)
19. Hutyrova B, Pantelidis P, Drabek J, Zurkova M, Kolek V, Len-hart K, Welsh KI, Du Bois RM, Petrek M. 2002. Interleukin-1 gene cluster polymorphisms in sarcoidosis and idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 165(2): 148-151. (Pubitemid 34084448)
20. Ikehara SK, Ikehara Y, Matsuo K, Hirose K, Niwa T, Ito H, Ito S, Kodera Y, Yamamura Y, Nakanishi H, Tatematsu M, Tajima K. 2006. A polymorphism of C-to-T substitution at-31 IL1B is associated with the risk of advanced gastric adenocarcinoma in a Japanese population. J Hum Genet 51(11):927-933. (Pubitemid 44800736)
21. Ito H, Kaneko K, Makino R, Konishi K, Kurahashi T, Yamamoto T, Katagiri A, Kumekawa Y, Kubota Y, Muramoto T, Mitamura K, Imawari M. 2007. Interleukin-1beta gene in esophageal, gastric and colorectal carcinomas. Oncol Rep 18(2):473-481.
22. Jin L, Yuan RQ, Fuchs A, Yao Y, Joseph A, Schwall R, Schnitt SJ, Guida A, Hastings HM, Andres J, Turkel G, Polverini PJ, Goldberg ID, Rosen EM. 1997. Expression of interleukin-1beta in human breast carcinoma. Cancer 80(3):421-434. (Pubitemid 27323412)
23. Kanemoto K, Kawasaki J, Miyamoto T, Obayashi H, Nishimura M. 2000. Interleukin (IL)1beta, IL-1alpha, and IL-1 receptor antagonist gene polymorphisms in patients with temporal lobe epilepsy. Ann Neurol 47(5):571-574. (Pubitemid 30261891)
24. Kaur G, Rapthap CC, Kumar N, Kumar S, Neolia S, Mehra NK. 2007. Frequency distribution of cytokine gene polymorphisms in the healthy North Indian population. Tissue Antigens 69(2): 113-120. (Pubitemid 46174864)
25. Lichtenstein M, Zimran A, Horowitz M. 1997. Cytokine mRNA in Gaucher disease. Blood Cells Mol Dis 23(3):395-401. (Pubitemid 28123721)
26. Machado JC, Pharoah P, Sousa S, Carvalho R, Oliveira C, Figueiredo C, Amorim A, Seruca R, Caldas C, Carneiro F, Sobrinho-Simoes M. 2001. Interleukin 1B and interleukin 1RN polymorphisms are associated with increased risk of gastric carcinoma. Gastroenterology 121(4):823-829. (Pubitemid 32959393)
27. Manilal A, Rani C, Sabarathnam B, Seghal KG, Selvin J, Sugathan S, et al. 2010. A comparative study on the prevalence of HCC seromarkers among tribal and coastal population. Iranica Journal of Energy and Environment 1(3):179-183.
28. Migita K, Maeda Y, Abiru S, Nakamura M, Komori A, Miyazoe S, Nakao K, Yatsuhashi H, Eguchi K, Ishibashi H. 2007. Polymorphisms of interleukin-1beta in Japanese patients with hepatitis B virus infection. J Hepatol 46(3):381-386. (Pubitemid 46185698)
29. Mittal RD, Bid HK, Manchanda PK. 2007. Genotype and haplotype determination of IL1B (g.-511C>T and g. + 3954C > T) and (IL1RN) in pediatric nephrolithiasis. Clin Chim Acta 379(1-2):42-47. (Pubitemid 46366965)
30. Neuveut C, Wei Y, Buendia MA. 2010. Mechanisms of HBV-related hepatocarcinogenesis. J Hepatol 52(4):594-604.
31. Pociot F, Molvig J, Wogensen L, Worsaae H, Nerup J. 1992. A TaqI polymorphism in the human interleukin-1 beta (IL-1 beta) gene correlates with IL-1 beta secretion in vitro. Eur J Clin Invest 22(6):396-402.
32. Sekiyama KD, Yoshiba M, Thomson AW. 1994. Circulating proinflammatory cytokines (IL-1 beta, TNF-alpha, and IL-6) and IL-1 receptor antagonist (IL-1Ra) in fulminant hepatic failure and acute hepatitis. Clin Exp Immunol 98(1):71-77. (Pubitemid 24315454)
33. Shindo M, Mullin GE, Braun-Elwert L, Bergasa NV, Jones EA, James SP. 1996. Cytokine mRNA expression in the liver of patients with primary biliary cirrhosis (PBC) and chronic hepatitis B (CHB). Clin Exp Immunol 105(2):254-259. (Pubitemid 26246942)
34. Stephens M, Smith NJ, Donnelly P. 2001. A new statistical method for haplotype reconstruction from population data. Am J Hum Genet 68(4):978-989. (Pubitemid 32289743)
35. Tanaka Y, Furuta T, Suzuki S, Orito E, Yeo AE, Hirashima N, Sugauchi F, Ueda R, Mizokami M. 2003. Impact of interleukin-1beta genetic polymorphisms on the development of hepatitis C virus-related hepatocellular carcinoma in Japan. J Infect Dis 187(11):1822-1825. (Pubitemid 36667895)
36. Tarlow JK, Blakemore AI, Lennard A, Solari R, Hughes HN, Steinkasserer A, Duff GW. 1993. Polymorphism in human IL-1 receptor antagonist gene intron 2 is caused by variable numbers of an 86-bp tandem repeat. Hum Genet 91(4): 403-404. (Pubitemid 23177503)
37. Tian Z, Shen X, Feng H, Gao B. 2000. IL-1 beta attenuates IFN-alpha beta-induced antiviral activity and STAT1 activation in the liver: involvement of proteasome-dependent pathway. J Immunol 165(7):3959-3965. (Pubitemid 32057305)
38. Trajkov D, Arsov T, Petlichkovski A, Strezova A, Efinska-Mladenovska O, Spiroski M. 2005. Cytokine gene polymorphisms in population of ethnic Macedonians. Croat Med J 46(4):685-692. (Pubitemid 41248195)
39. Um JY, Moon KS, Lee KM, Yun JM, Cho KH, Moon BS, Kim HM. 2003. Association of interleukin-1 alpha gene polymorphism with cerebral infarction. Brain Res Mol Brain Res 115(1):50-54.
40. Zhang PA, Li Y, Xu P, Wu JM. 2004. Polymorphisms of inter-leukin-1B and interleukin-1 receptor antagonist genes in patients with chronic hepatitis B. World J Gastroenterol 10(12): 1826-1829. (Pubitemid 38931215)
41. Zhou L, Liu J, Luo F. 2006. Serum tumor markers for detection of hepatocellular carcinoma. World J Gastroenterol 12(8): 1175-1181.